Prism Capital is a Chicago-based private equity firm currently in wind-down. Prism managed both the Prism Opportunity Fund, a growth equity fund, and the Prism Mezzanine Fund, a lower-middle market subordinated debt fund. Prism Opportunity Fund invested in 14 companies, including: SecurePipe, a digital security firm which merged with Trustwave; Celleration, a medical device company sold to Alliqua BioMedical; HighBeam Research, sold to Gale (part of Cengage Learning); SterilMed, sold to Great Hill Partners and Primus Capital; Banner Service Corp; and Fieldglass, sold to Madison Dearborn Partners. Prism Mezzanine Fund invested in 26 companies including: Angie’s List which went public, Trans-Coil, Hi-Tech Manufacturing, Hill & Valley, Ott-Lite and DeIorio.
Prism, founded in 1999, invested in and supported over 40 businesses. In 2011, its Partners began winding down the fund to pursue other interests. We remain actively involved in winding down the remaining fund’s assets on behalf of our Limited Partners.